Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | ||||||
---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|||||
Investment income | ||||||||
Total investment income | $ 51,464,997 | $ 71,526,225 | $ 107,353,912 | $ 127,255,534 | ||||
Operating expenses | ||||||||
Interest and other debt expenses | 17,087,833 | 19,726,829 | 34,172,466 | 32,957,053 | ||||
Management fees | 5,461,118 | 6,563,189 | 10,944,962 | 12,382,694 | ||||
Professional fees | 947,452 | 681,923 | 1,814,899 | 1,601,599 | ||||
Administrative expenses | 509,930 | 594,208 | 1,151,394 | 1,155,211 | ||||
Insurance expense | 218,463 | 205,953 | 436,926 | 351,066 | ||||
Director fees | 192,500 | 197,500 | 385,000 | 414,219 | ||||
Custody fees | 91,348 | 99,145 | 184,533 | 189,065 | ||||
Incentive fees | 0 | 6,815,672 | 0 | 12,696,050 | ||||
Other operating expenses | 1,182,050 | 816,274 | 2,114,708 | 1,421,772 | ||||
Total operating expenses, before management fee waiver | 25,690,694 | 35,700,693 | 51,204,888 | 63,168,729 | ||||
Management fee waiver (Note 3) | (1,820,372) | 0 | (3,648,320) | 0 | ||||
Total operating expenses, after management fee waiver | 23,870,322 | 35,700,693 | 47,556,568 | 63,168,729 | ||||
Net investment income | 27,594,675 | 35,825,532 | 59,797,344 | 64,086,805 | ||||
Net realized gain (loss): | ||||||||
Net realized gain (loss) | (66,297,375) | (35,513,930) | (107,214,713) | (35,682,007) | ||||
Net change in unrealized appreciation (depreciation): | ||||||||
Net change in unrealized appreciation (depreciation) | [1] | 22,796,116 | (51,588,119) | 52,405,373 | (74,624,174) | |||
Net realized and unrealized gain (loss) | (43,501,259) | (87,102,049) | (54,809,340) | (110,306,181) | ||||
Net increase (decrease) in net assets resulting from operations | $ (15,906,584) | $ (51,276,517) | $ 4,988,004 | $ (46,219,376) | ||||
Basic earnings (loss) per share | $ (0.19) | $ (0.6) | $ 0.06 | $ (0.63) | ||||
Diluted earnings (loss) per share | $ (0.19) | $ (0.6) | $ 0.06 | $ (0.63) | ||||
Basic weighted average common shares outstanding | 85,042,931 | 85,591,134 | 85,060,179 | 73,819,497 | ||||
Diluted weighted average common shares outstanding | 85,042,931 | 85,591,134 | 85,060,179 | 73,819,497 | ||||
Non-Controlled, Non-Affiliated Investments | ||||||||
Investment income | ||||||||
Interest income (excluding PIK) | $ 41,609,217 | $ 63,562,637 | $ 85,065,954 | $ 112,208,830 | ||||
PIK interest income | 5,449,424 | 2,034,356 | 11,238,339 | 4,440,033 | ||||
Dividend income | 449,575 | 594,372 | 885,526 | 906,696 | ||||
Other income | 1,399 | 3,293 | 1,965 | 5,346 | ||||
Net realized gain (loss): | ||||||||
Net realized gain (loss) | (66,287,884) | (22,703,792) | (107,205,222) | (22,871,869) | ||||
Net change in unrealized appreciation (depreciation): | ||||||||
Net change in unrealized appreciation (depreciation) | [1] | 40,313,699 | (57,619,007) | 66,868,692 | (63,771,066) | |||
Non-Controlled, Affiliated Investments | ||||||||
Investment income | ||||||||
Interest income (excluding PIK) | 338,648 | 384,684 | 676,647 | 732,319 | ||||
PIK interest income | 0 | 0 | 0 | 92,675 | ||||
Dividend income | 213,493 | 1,018,486 | 1,222,550 | 1,732,189 | ||||
Net realized gain (loss): | ||||||||
Net realized gain (loss) | 0 | (12,810,138) | 0 | (12,810,138) | ||||
Net change in unrealized appreciation (depreciation): | ||||||||
Net change in unrealized appreciation (depreciation) | [1] | (3,203,412) | 8,310,670 | (2,282,254) | (6,067,358) | |||
Controlled Investments | ||||||||
Investment income | ||||||||
Interest income (excluding PIK) | 2,270,542 | 2,696,570 | 4,579,811 | 5,555,650 | ||||
PIK interest income | 394,202 | 353,752 | 1,075,763 | 703,721 | ||||
Dividend income | 738,497 | [1] | 878,075 | [1] | 2,607,357 | 878,075 | ||
Net change in unrealized appreciation (depreciation): | ||||||||
Net change in unrealized appreciation (depreciation) | [1] | (14,296,084) | (2,137,940) | (12,171,749) | (4,650,847) | |||
Interest Rate Swap | ||||||||
Net realized gain (loss): | ||||||||
Net realized gain (loss) | (9,491) | 0 | (9,491) | 0 | ||||
Net change in unrealized appreciation (depreciation): | ||||||||
Net change in unrealized appreciation (depreciation) | [1] | $ (18,087) | $ (141,842) | $ (9,316) | $ (134,903) | |||
|
X | ||||||||||
- Definition Director fees. No definition available.
|
X | ||||||||||
- Definition Incentive fees on income. No definition available.
|
X | ||||||||||
- Definition Investment income payment in kind interest income. No definition available.
|
X | ||||||||||
- Definition Management fees. No definition available.
|
X | ||||||||||
- Definition Management fees waiver No definition available.
|
X | ||||||||||
- Definition Other operating expenses. No definition available.
|
X | ||||||||||
- Definition Total operating expenses before management fee waiver. No definition available.
|
X | ||||||||||
- Definition Those fees charged for services related to holding, advising, and managing customer investment assets. These account fees usually charged annually or semi-annually, on a per security basis, for the costs of services. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of realized and unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The expense in the period incurred with respect to protection provided by insurance entities against risks other than risks associated with production (which are allocated to cost of sales). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Interest and debt related expenses associated with nonoperating financing activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of dividend income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount of realized gain (loss) on investment. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|